RetinaRounds™

30: RetinaRounds™ Podcast 30: Jay Duker, MD

58 min · 21 de dic de 2025
portada del episodio 30: RetinaRounds™ Podcast 30: Jay Duker, MD

Descripción

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de RetinaRounds™!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

31 episodios

episode 30: RetinaRounds™ Podcast 30: Jay Duker, MD artwork

30: RetinaRounds™ Podcast 30: Jay Duker, MD

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

21 de dic de 202558 min